Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis-Reference-Cited by-同舟云学术

Risk prediction algorithms in guiding antiviral therapy initiation among patients with chronic hepatitis B in Thailand: an economic evaluation and budget impact analysis

Published:2023-07-04 Issue:8 Volume:23 Page:951-958
ISSN:1473-7167
Container-title:Expert Review of Pharmacoeconomics & Outcomes Research
language:en
Short-container-title:Expert Review of Pharmacoeconomics & Outcomes Research

Author:

Dilokthornsakul Piyameth¹²,Sawangjit Ratree³,Tangkijvanich Pisit⁴,Chayanupatkul Maneerat⁵,Sriuttha Pajaree¹²,Permsuwan Unchalee¹²

Affiliation:

1. Center of Medical and Health Technology Assessment (CM-HTA), Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand

2. Department of Pharmaceutical Care, Faculty of Pharmacy, Chiang Mai University, Chiang Mai, Thailand

3. Clinical Trial and Evidence-Based Synthesis Research Unit, Department of Clinical Pharmacy, Faculty of Pharmacy, Mahasarakham University, Mahasarakham, Thailand

4. Center of Excellence in Hepatitis and Liver Cancer, Department of Biochemistry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

5. Center of Excellence in Alternative and Complementary Medicine for Gastrointestinal and Liver Diseases, Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand

Funder

the Ratchadapisek Sompoch Endowment Fund, Chulalongkorn University

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Health Policy,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14737167.2023.2231636

Reference41 articles.

1. The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level

2. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study

3. Access to Treatment for Hepatitis B Virus Infection — Worldwide, 2016

4. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

5. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simplified Chronic Hepatitis B Antiviral Initiation Criteria in Thailand: An Economic Evaluation;Value in Health Regional Issues;2024-09